The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans-Reference-Cited by-同舟云学术

The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans

Published:2014-05-26 Issue:1 Volume:4 Page:25-32
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:

Author:

Barve Avantika¹,Kovacs Steven J.¹,Ke June¹,Crabbe Rafael²,Grosgurin Peter²,Menetrey Annick²,Nicolas-Métral Valerie²,Dabovic Kristina¹,Dole Kiran³,Zhang Jie¹,Praestgaard Jens¹,Sunkara Gangadhar¹,Stein Daniel¹

Affiliation:

1. Novartis Institutes for Biomedical Research; East Hanover NJ USA

2. Debiopharm International SA; Lausanne Switzerland

3. Novartis Institutes for Biomedical Research; Cambridge MA USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.114/fullpdf

Reference12 articles.

1. An evaluation of the cyclophilin inhibitor Debio 025 and its potential as a treatment for chronic hepatitis C;Crabbe;Expert Opin Invest Drugs.,2009

2. Host-targeting agents in the treatment of hepatitis C: a beginning and an end;Baugh;Antiviral Res.,2013

3. Profile of alisporivir and its potential in the treatment of hepatitis C;Gallay;Drug Des Devel Ther.,2013

4. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics erythromycin, clarithromycin and the azalide azithromycin;Yeates;Int J Clin Pharmacol.,1996

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclophilin inhibition as a strategy for the treatment of human disease;Frontiers in Pharmacology;2024-07-08

2. Therapeutic Drug Monitoring of Blood Sirolimus and Tacrolimus Concentrations for Polypharmacy Management in a Lymphangioleiomyomatosis Patient Taking Two Cytochrome P450 3A Inhibitors;The Tohoku Journal of Experimental Medicine;2023

3. Pharmacokinetics and Bioequivalence of 2 Azithromycin Tablet Formulations: A Randomized, Open‐Label, 2‐Stage Crossover Study in Healthy Volunteers;Clinical Pharmacology in Drug Development;2022-04-08

4. The detoxification effect of cytochrome P450 3A4 on gelsemine-induced toxicity;Toxicology Letters;2021-12